Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.05/sh

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.05). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.07 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
• Sysco raises mid-term targets, unveils $500M AI efficiency program
• Cognyte Software (CGNT) Tops Q2 EPS by 4c